Ted Henderson — SCHOONER CAPITAL

TEAM

Vin Ryan
Rachel Billings
Peter Binas
Antonio Cienfuegos
Jon Corbett
Laurie Finkielsztein
Phoebe Gantner
Orhan Gazelle
Ted Henderson
Solita Im
Steve Maiocco
Alexandra Manick
Julia Pettengill
Brian Rodgers
Lou Stathis

TED HENDERSON

Ted serves as President and CEO of Schooner Capital. Over the past several decades, he led the firm’s migration back to its roots in direct investing. A Managing Partner, Ted invests primarily in venture and growth stage private companies with time allocated to internal management, asset allocation and firm strategy. He led a number of Schooner healthcare sector investments including 4G Clinical (acquired by Goldman Sachs Asset Management), Cartesian Therapeutics (NASDAQ:RNAC), Millstone Medical Outsourcing (acquired by Arlington Capital), Topokine Therapeutics (acquired by Allergan), Mimetogen Pharmaceuticals (acquired by Allergan), and Best Doctors (acquired by Brown Brothers). He also led or co-led investments in Seventh Generation (acquired by Unilever), MediaSilo (acquired by Marlin Equity), and StyleFeeder (acquired by Time Inc.). He currently is a director at Brixton Biosciences, Spotted Risk, SRS Medical, and Zixi. Ted is a past director at several not-for-profits and co-chaired Friends of Dartmouth Soccer for a number of years. He has an MBA from Harvard Business School and graduated cum laude from Dartmouth College, studying Mandarin.